Copertina

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Amanda Massmann, Jordan F. Baye, Max Weaver
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
di: Majid Khalilizad, et al.
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

Response to Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
di: Keisuke Mine, et al.
Pubblicazione: (2025)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
di: Amy Broadwater, et al.
Pubblicazione: (2026)

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
di: Saurabh Rahurkar, et al.
Pubblicazione: (2025)

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
di: Eugene Jeong, et al.
Pubblicazione: (2025)

Machine Learning‐Based Prediction of Prolonged Duration of Mechanical Ventilation Using Medication Data
di: Brian Murray, et al.
Pubblicazione: (2026)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
di: Wenqiang Zhou, et al.
Pubblicazione: (2026)

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
di: Youjun Chen, et al.
Pubblicazione: (2025)

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
di: Adrian Valadez, et al.
Pubblicazione: (2026)

Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies
di: Simone Giuliano, et al.
Pubblicazione: (2025)

Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
di: Casey L. Keller, et al.
Pubblicazione: (2026)

Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma
di: Milre M. Matherne, et al.
Pubblicazione: (2026)

Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study
di: Arden R. Barry, et al.
Pubblicazione: (2025)

Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study
di: Keisuke Mine, et al.
Pubblicazione: (2025)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
di: William L. Baker, et al.
Pubblicazione: (2026)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Pubblicazione: (2025)

Factors That Influence Blood Pressure Changes With the Use of Sodium‐Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes
di: Sara Salama, et al.
Pubblicazione: (2026)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
di: Erin F. Barreto, et al.
Pubblicazione: (2026)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
di: Aya M. AbdelMagid, et al.
Pubblicazione: (2026)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
di: Amira R. Rashdan, et al.
Pubblicazione: (2026)

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
di: Sandra L. Kane‐Gill
Pubblicazione: (2025)

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
di: Yaping Zhan, et al.
Pubblicazione: (2025)

DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
di: Alfred Zheng Ting Ho, et al.
Pubblicazione: (2026)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
di: Jyotirmoy Sarker, et al.
Pubblicazione: (2024)

Cost‐Effectiveness Analysis of Patient Self‐Management of Warfarin Among Patients With Non‐Valvular Atrial Fibrillation
di: Warittakorn Kategeaw, et al.
Pubblicazione: (2026)

Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity
di: Yoshihiko Matsuki, et al.
Pubblicazione: (2026)

Pharmacokinetics of Sulbactam/Durlobactam in a Patient With Acute Renal Failure, Severe Obesity, and Carbapenem‐Resistant Acinetobacter baumannii Bacteremia: A Case Report
di: Dan Ilges, et al.
Pubblicazione: (2025)

The Use of Plasma Exchange for Clozapine Intoxication: A Case Report
di: Bradley J. Peters, et al.
Pubblicazione: (2025)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
di: Caroline Chen, et al.
Pubblicazione: (2025)

DPYD and fluoropyrimidines: Using the data as our guide
di: Christine M. Walko
Pubblicazione: (2024)

Continuous Subcutaneous Ketamine Infusion May Induce Tacrolimus and Sirolimus Clearance: A Case Report
di: Jana Stojanova, et al.
Pubblicazione: (2026)

Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study
di: Grace Hsin‐Min Wang, et al.
Pubblicazione: (2025)

Effectiveness of Stimulant Treatment in Preventing Fractures and Head Injuries in Patients With Narcolepsy: A Self‐Controlled Case Series Study
di: Yunlong Zheng, et al.
Pubblicazione: (2026)

Prescription Sequence Symmetry Analysis for Detection of Chronic Opioid Use Adverse Event Signals Using Administrative Claims Data
di: Efstathia Polychronopoulou, et al.
Pubblicazione: (2025)

Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi‐site retrospective study
di: Maria‐Stephanie A. Hughes, et al.
Pubblicazione: (2024)

Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
di: Yongyi Zhang, et al.
Pubblicazione: (2024)

Warfarin dosage in a postpartum woman while breastfeeding: A case report
di: Ellen Uppuluri, et al.
Pubblicazione: (2024)